Even at therapeutic doses, it can harm people with chronic liver diseases
Clinical data reveals Retatrutide dropped A1C from 8.1% to 6.08% in diabetic participants
JAMA, 318(15), 1460-1470
Early qualitative studies and longitudinal surveys will be needed to assess changes in self-esteem, body image, eating behaviors, and the risk of disordered eating
Showed up wrapped super insanely good and now look at these bestiesRaquel KeenanRated 5 out of 5January 7, 2026GlutathioneGreat product and great serviceWendy TannoRated 5 out of 5December 13, 2025Quality product great serviceProduct is high quality and very quick delivery
Robert Lustig, MD, MSL, is Professor Emeritus of Pediatrics in the Division of Endocrinology at the University of California, San Francisco